CelLBxHealth ANPCY Stock
CelLBxHealth Price Chart
CelLBxHealth ANPCY Financial and Trading Overview
| CelLBxHealth stock price | 0.07 USD |
| Previous Close | 2.08 USD |
| Open | 2.49 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 2.08 - 2.08 USD |
| 52 Week Range | 2.08 - 13.41 USD |
| Volume | 8 USD |
| Avg. Volume | 147 USD |
| Market Cap | 58.31M USD |
| Beta (5Y Monthly) | 0.51226 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.65 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ANPCY Valuation Measures
| Enterprise Value | 27.28M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 56.01034 |
| Price/Book (mrq) | 1.3506494 |
| Enterprise Value/Revenue | 26.208 |
| Enterprise Value/EBITDA | -1.223 |
Trading Information
CelLBxHealth Stock Price History
| Beta (5Y Monthly) | 0.51226 |
| 52-Week Change | -84.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13.41 USD |
| 52 Week Low | 2.08 USD |
| 50-Day Moving Average | 2.98 USD |
| 200-Day Moving Average | 4.68 USD |
ANPCY Share Statistics
| Avg. Volume (3 month) | 147 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 26.06M |
| Float | 19.04M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.0040% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2325.36% |
| Gross Margin | 58.88% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -31.13% |
| Return on Equity (ttm) | -53.94% |
Income Statement
| Revenue (ttm) | 1.04M USD |
| Revenue Per Share (ttm) | 0.04 USD |
| Quarterly Revenue Growth (yoy) | -13.20% |
| Gross Profit (ttm) | 613K USD |
| EBITDA | -22309000 USD |
| Net Income Avi to Common (ttm) | -21686000 USD |
| Diluted EPS (ttm) | -1.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 31.9M USD |
| Total Cash Per Share (mrq) | 1.23 USD |
| Total Debt (mrq) | 5M USD |
| Total Debt/Equity (mrq) | 12.48 USD |
| Current Ratio (mrq) | 7.358 |
| Book Value Per Share (mrq) | 1.54 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16050000 USD |
| Levered Free Cash Flow (ttm) | -9029375 USD |
Profile of CelLBxHealth
| Country | United States |
| State | N/A |
| City | Guildford |
| Address | Surrey Research Park |
| ZIP | GU2 7AF |
| Phone | 44 14 8334 3434 |
| Website | https://angleplc.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Q&A For CelLBxHealth Stock
What is a current ANPCY stock price?
CelLBxHealth ANPCY stock price today per share is 0.07 USD.
How to purchase CelLBxHealth stock?
You can buy ANPCY shares on the OTC Markets OTCQX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CelLBxHealth?
The stock symbol or ticker of CelLBxHealth is ANPCY.
Which industry does the CelLBxHealth company belong to?
The CelLBxHealth industry is Diagnostics & Research.
How many shares does CelLBxHealth have in circulation?
The max supply of CelLBxHealth shares is 381.26M.
What is CelLBxHealth Price to Earnings Ratio (PE Ratio)?
CelLBxHealth PE Ratio is now.
What was CelLBxHealth earnings per share over the trailing 12 months (TTM)?
CelLBxHealth EPS is -0.65 USD over the trailing 12 months.
Which sector does the CelLBxHealth company belong to?
The CelLBxHealth sector is Healthcare.